Quantitative PCR-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study

Haematologica. 2020 Sep 10;106(5):1480-1483. doi: 10.3324/haematol.2019.238543.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Marrow
  • Bone Marrow Transplantation
  • Chimerism*
  • Humans
  • Leukemia, Myeloid, Acute* / diagnosis
  • Leukemia, Myeloid, Acute* / genetics
  • Polymerase Chain Reaction
  • Prospective Studies
  • Recurrence
  • Transplantation Chimera

Grants and funding

Funding: the study was supported by the Italian Ministry of Health (RF-2011-02351998 to FC and LV, RF-2011-02348034 to LV and TRANSCAN HLALOSS to LV), by the Associazione Italiana per la Ricerca sul Cancro (Start-Up Grant #14162 to LV) and by the DKMS Mechtild Harf Foundation (DKMS Mechtild Harf Research Grant 2015 to LV).